Net profit of Indo US Bio-Tech rose 28.46% to Rs 1.67 crore in the quarter ended September 2023 as against Rs 1.30 crore during the previous quarter ended September 2022. Sales rose 14.98% to Rs 15.81 crore in the quarter ended September 2023 as against Rs 13.75 crore during the previous quarter ended September 2022.